Decide Breast Cancer Treatment thats Best for YOU
We’ve helped thousands of patients decide on their breast cancer treatment plan
When It Comes To Breast Cancer Trust the Innovators of the BRCA gene
Similar to people, no two breast cancers are the same. Myriad develops tests designed to empower you to make informed treatment decisions that are unique to your breast cancer.
What does Myriad provide?
Myriad is able to provide industry leading results that are specific to your breast cancer by investigating changes in your DNA. Armed with this information, you and your doctor no longer have to use a one size fits all approach. You can start creating a treatment plan that is personalized to you.
What is Hereditary Breast and Ovarian Cancer?
Learn More about Breast Cancer
What Answers Do Genetic Test Provide?
HEREDITARY CANCER TESTING
BREAST CANCER TUMOR TESTING – TO GUIDE TREATMENT AND RISK MANAGEMENT DECISIONS
EndoPredict® allows you to decide if you can safely avoid chemotherapy. It is a breast cancer recreance test that tells your 10 year risk of recurrence. Each test gives you a clear yes or no answer.
Hereditary Cancer Testing for Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2)
BRACAnalysis ® is a genetic test that detects the presence of a BRCA1 or BRCA2 gene mutation. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87 percent for developing breast cancer and 39-63 percent for developing ovarian cancer by age 70.
BREAST CANCER TREATMENT OPTIONS
PositiveSelect Plus provides patients with treatment options such as chemotherapy, targeted therapy and immunotherapy options.
Tumor Normal Match For Breast Cancer Treatment Options
PositiveSelect Ultimate is a genetic test that tests both cancer cells as well as normal blood cells. In addition to the PositiveSelect Plus test benefits, PositiveSelect Ultimate identifies somatic and germ line mutations.
Why Hereditary Testing for Breast Cancer?
Knowing whether your cancer was caused by a genetic mutation will help guide treatment decisions, determine your risk of developing additional cancers (like a second breast cancer or ovarian cancer), and identify your close family members’ risks of having the same mutation.
If your cancer was caused by a genetic mutation, your children and siblings have a 50% chance of being diagnosed with that same mutation. Genetic testing for breast cancer helps identify multiple genetic mutations that are related to breast cancer, such as BRCA1 and BRCA2, and people with mutations in these genes have up to an 87% risk of developing breast cancer by 70. These individuals are also at a much higher risk of developing other cancers, like ovarian and pancreatic, than the general public.